Fziomed, Inc. Named One of the 2026 Best Places to Work in Southern California

Fziomed is headquartered in San Luis Obispo, California, and has been named one of the Best Places to Work in Southern California for the past four consecutive years.

SAN LUIS OBISPO, Calif., Sept. 2, 2026 /PRNewswire/ -- Fziomed, Inc. ("Fziomed" or the "Company"), a global leader in adhesion prevention biomaterials and surgical innovation, today announced it was recently named one of the 2026 Best Places to Work in Southern California. This marks the fourth consecutive year the Company has been recognized by the annual program organized by Best Companies Group (BCG), a BridgeTower Media company.

Fziomed CEO Paul Mraz commented, "We are honored to once again be recognized as one of the Best Places to Work in Southern California. This award is especially meaningful because it reflects the candid feedback of our employees. Their perspectives help us understand how we can continue strengthening the empowering and purpose-driven culture that makes Fziomed such a special place to work. We remain committed to our Vision – what we call 'the Why' – and to giving every team member the opportunity to make a meaningful difference in the lives of the more than 1 million patients treated with our products, the clinicians who use our products, and our partners around the world. We are proud to see that commitment reflected in this recognition."

BCG selects the winners based on responses from detailed, anonymous employee surveys and ranks companies across small, medium, and large company categories. The rankings are based on an analysis of employee feedback on corporate culture, training and development, compensation and benefits, and overall employee satisfaction. Southern California companies that meet certain criteria and rank highest on issues that matter most to employees are recognized.

About Fziomed, Inc.
Pioneering biomaterials since 1996 and having helped more than 1 million patients globally, Fziomed is a recognized global leader in postsurgical adhesion prevention, focused on addressing unmet clinical needs in spine, tendon, nerve, abdominal, pelvic, and intrauterine procedures. Fziomed develops, manufactures, and commercializes best-in-class surgical biomaterials used by clinicians to Preserve Surgical Excellence^SM and improve patient outcomes.

Fziomed's synthetic, absorbable gel formulations are based on the Company's proprietary dual-polymer technology platform that provide a temporary, physical separation of tissues during the body's natural healing process – reducing adhesion formation. Fziomed's portfolio of adhesion barrier products are marketed in more than 70 countries under various brand names and have been used clinically since 2002.

Fziomed is headquartered in San Luis Obispo, California, and has been named one of the Best Places to Work in Southern California for the past four consecutive years.

Visit fziomed.com to learn more about Fziomed and our industry-leading products.

SOURCE Fziomed, Inc.